Serum Copeptin - A Diagnostic marker of Acute Myocardial Infarction

Authors

  • Anuradha G Sri Muthukumaran Medical College and Research Institute
  • Mahalakshmi R. Tagore Medical College and Hospital Rathinamangalam Melakkottaiyur Post Chennai-600 127

DOI:

https://doi.org/10.7439/ijbar.v9i7.4797

Keywords:

periodontium, infections, rheumatoid arthritis, diabetes mellitus

Abstract

The Present study aim is to measure the level of Copeptin in serum of acute myocardial infarction patients and to correlate it with serum CK-MB level. S.Copeptin and S.CK-MB level was estimated in 60 cases of AMI and 60 controls.Mean

Downloads

Download data is not yet available.

Author Biography

  • Anuradha G, Sri Muthukumaran Medical College and Research Institute
    biochemistry,assistant professor

References

Prashant Kr. Dhakad and Pramod Kr. Sharma Cardiac biomarkers: A boon for diagnosis of acute myocardial infarction patients. Library, Annals of Biological Research, 2015, 6 (1): 1-5.

Intan Nureslyna Samsudin 1, Ilyas Syafq Darul Ridzuan 1, Subashini C. Thambiah1, SharifulHasan. Utility of copeptin in acute myocardial infarction International Journal of Public Health and Clinical Sciences 2015; 2(3).

Vasudevan D.M., Sreekumari. S, Kannan Vaidyanathan, Cardio vascular diseases and Hyperlipidemias, Text Book of Biochemistry for Medical Students, 6th edition, Jaypee Brothers Medical Publishers (P) Ltd, 2011, p.292.

Manchanda S.C. Ischemic Heart Disease. 3rd edition. New Delhi: CBS Publishers and Distributors; 1999.p.287-288.

Mingo- Chao Lin, Fanny Almus - Jacobs, Hsuan Hsu Chen, et al. Shear stress Induction of the Tissue Factor Gene.j.Clin. Invest.1997; Volume 99, Number 4: February 737-744.

Sabesanmythili and Narasimhanmalathi. Diagnostic markers of acute myocardial infarction (Review), Biomedical reports 2015.; 3: 743-748;

Martin Mockel, Julia Searle, Christian Hamm, Anna Slagman, Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. European Heart Journal Advance 2014; 30. Doi: 10. 1093/eurheartj/ehu 178.

Padmaja. V, Deepu. P, Cardiac Biomarkers, Hygeia 2009; 1(1).

Sathyamurthy I., Jamshed J Dalal, JPS Sawhney, JC Mohan et al, Cardiac Biomarkers for Better Management of Acute Coronary Syndromes, Journal of The Associations of Physicians of India, 2015; 63.

Nagesh C.M. & Roy Ambuj, Role of biomarkers in risk stratification of acute coronary syndrome, Indian J Med Res 2010, 132: 627 – 633.

Daniel Chan and Leong L Ng, Biomarkers in acute myocardial infarction, Bio Med Central Pub, Medicine 2010; 8:34.

Joshua Rosenblat, Angela Zhang, Thomas Fear, Biomarkers of myocardial infarction: past, present and future, UWOMJ, 2012; 81(1).

Judd E. Hollander, The future of Cardiac Biomarkers, New Concepts and Emerging Technologies for Emergency Physicians, Emergency Medicine Cardiac Research and Education Group, 2005; 4.

Nils G. Morgenthaler, MD, MBA, copeptin: a new cardiovascular biomarker, supplement 1, July – August 2010, doi: 10.1111/j.1751-7133.2010.00177.x.,S37-S44.

Shrabani Mohanty and Asha. G, A novel stress neuro hormone copeptin: its potential role in diagnosis and prognosis of various diseases, World Journal of Pharmaceutical Research, 2015; 4(1).

Stephan Baldus, Christopher Heeschen, Thomas Meinertz, Andreas M. Zeiher, Jason P. Eiserich, Thomas Munzel, Maarten L. Simoons, Christian W. Hamm, on behalf of the CAPTURE Investigators, Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes, NCBI Resources, E pub 2003.; 108 ( 12): 1440-5.

Downloads

Published

2018-07-31

Issue

Section

Original Research Articles

How to Cite

Serum Copeptin - A Diagnostic marker of Acute Myocardial Infarction. (2018). International Journal of Biomedical and Advance Research, 9(7), 259-260. https://doi.org/10.7439/ijbar.v9i7.4797